GRML (Greenland Mines) Common Stock: $0.01 Mil (As of Mar. 2026)


GRML Greenland Mines Ltd GRML
12 GF Score
Price $0.25
! 1 Warning Sign
View Full Analysis

What is Greenland Mines Common Stock?

Greenland Mines GRML +0.33% 12 Common Stock is $0.01 Mil as of Mar. 2026. GuruFocus rates GRML with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Greenland Mines's quarterly common stock stayed the same from . 20 ($0.00 Mil) to Mar. 2025 ($0.00 Mil) but then increased from Mar. 2025 ($0.00 Mil) to Mar. 2026 ($0.01 Mil).

Greenland Mines Common Stock Historical Data

* Premium members only.

The historical data trend for Greenland Mines's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenland Mines Common Stock Chart

Greenland Mines Annual Data
Trend
Common Stock

Greenland Mines Semi-Annual Data
Mar25 Mar26
Common Stock 0.00 0.01
GRML
12GF Score
Greenland Mines Ltd GRML
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenland Mines Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.01 Mil mean?
Greenland Mines (GRML) has a Common Stock of $0.01 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Greenland Mines and its competitors.
Is Greenland Mines' Common Stock too high?
Greenland Mines' current Common Stock is $0.01 Mil. Overall, Greenland Mines has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Greenland Mines' Common Stock compare to SRGZ and RITE?
Greenland Mines' Common Stock of $0.01 Mil can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Metals & Mining company?
A good Common Stock depends on the Metals & Mining industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Greenland Mines and its competitors. Greenland Mines's current Common Stock is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenland Mines stock overvalued right now?
Greenland Mines (GRML) has a current Common Stock of $0.01 Mil. The current Common Stock is $0.01 Mil. Greenland Mines' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Greenland Mines (GRML), the current Common Stock is $0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Greenland Mines Business Description

Address 1300 South Boulevard, Unit D, Charlotte, NC, USA, 28203
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
12GF Score

Get the complete analysis for GRML

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price